Compare · GEHC vs NNOX
GEHC vs NNOX
Side-by-side comparison of GE HealthCare Technologies Inc. (GEHC) and NANO-X IMAGING LTD (NNOX): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both GEHC and NNOX operate in Medical Electronics (Health Care), so they compete in similar markets.
- GEHC is the larger of the two at $28.69B, about 368.1x NNOX ($77.9M).
- Over the past year, GEHC is down 17.0% and NNOX is down 77.8% - GEHC leads by 60.8 points.
- GEHC has been more active in the news (7 items in the past 4 weeks vs 3 for NNOX).
- GEHC has more recent analyst coverage (25 ratings vs 4 for NNOX).
- Company
- GE HealthCare Technologies Inc.
- NANO-X IMAGING LTD
- Price
- $63.06-4.01%
- $1.14+5.56%
- Market cap
- $28.69B
- $77.9M
- 1M return
- -0.22%
- -33.72%
- 1Y return
- -16.99%
- -77.82%
- Industry
- Medical Electronics
- Medical Electronics
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 7
- 3
- Recent ratings
- 25
- 4
NANO-X IMAGING LTD
Nano-X Imaging Ltd., a development-stage company, develops, produces, and commercializes digital X-ray source technology for the medical imaging industry worldwide. Its X-ray source is based on a novel digital MEMs semiconductor cathode. The company also develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. Nano-X Imaging Ltd. was founded in 2011 and is headquartered in Neve Ilan, Israel.
Latest GEHC
- Catholic Health and GE HealthCare partner to expand patient access across Long Island
- BMO Capital Markets initiated coverage on GE HealthCare with a new price target
- GE HealthCare and Mayo Clinic aim to advance personalized cancer treatment through new theranostics research collaboration
- GE HealthCare to announce second quarter 2026 results on July 29, 2026
- GE HealthCare announces cash dividend for second quarter of 2026
- GE HealthCare introduces Allia upgrade pathways designed to modernize existing interventional suites
- RBC Capital Mkts initiated coverage on GE HealthCare with a new price target
- GE HealthCare advancing enterprise imaging with cloud-enabled solutions
- GE HealthCare receives FDA 510(k) clearance for MIM Contour ProtégéAI+ 2.0, advancing AI-enabled radiation therapy planning with expanded clinical capabilities
- SEC Form SD filed by GE HealthCare Technologies Inc.
Latest NNOX
- Nano-X Imaging downgraded by Alliance Global Partners with a new price target
- New Clinical Study Data, Featuring Nanox.AI Cardiac Solution to Be Presented at SCCT 2026
- SEC Form 6-K filed by NANO-X IMAGING LTD
- Director Alroy Erez sold $1,119 worth of Ordinary Shares (678 units at $1.65), increasing direct ownership by 145% to 17,075 units (SEC Form 4)
- Nanox to Report First Quarter 2026 Financial Results on June 25, 2026
- Exclusive distribution agreement marks Nanox's entry into the Peruvian market
- Amendment: SEC Form SCHEDULE 13G/A filed by NANO-X IMAGING LTD
- Real-Time Intoxication Detection Platforms Target Expanding Multibillion-Dollar Healthcare Opportunities
- Nanox Announces Distribution Agreement with NuvioDx to Support Deployment of Nanox.ARC Systems
- SEC Form 20-F filed by NANO-X IMAGING LTD